Renal function and risk of coronary heart disease in general populations: New prospective study and systematic review

PLoS Medicine

Volumn 4, Issue 9, 2007, Pages 1497-1507

  Di Angelantonio, Emanuele ^a   Danesh, John ^a   Eiriksdottir, Gudny ^b   Gudnason, Vilmundur ^b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ICELANDIC HEART ASSOCIATION   (Iceland)

^c UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CREATININE BLOOD LEVEL; DISEASE MARKER; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MEASUREMENT; MORTALITY; POPULATION RESEARCH; PREDICTION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; ANIMAL; CORONARY ARTERY DISEASE; HEALTH SURVEY; KIDNEY DISEASE; KIDNEY FUNCTION TEST; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; CORONARY DISEASE; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34848857033     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040270     Document Type: Article

References (48)

1. Baigent C, Burbury K, Wheeler D. (2000) Premature cardiovascular disease in chronic renal failure. Lancet 356: 147-152.
2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, et al. (2003) Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169.
3. Anavekar NS, McMurray JJV, Velazquez EJ, Solomon SD, Kober L, et al. (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-1295.
4. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, et al. (2006) Renal impairment and outcomes in heart failure: Systematic review and meta-analysis. J Amer Coll Cardiol 47: 1987-1996.
5. Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr., et al. for the ALLHAT Collaborative Research Group (2006) Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 144: 172-180.
6. Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf Sfor the HOPE Investigators (2001) Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134: 629-636.
7. Brosius FC III, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, et al. (2006) Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: A Science Advisory From the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in collaboration with the National Kidney Foundation. Circulation 114: 1083-1087.
8. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, et al. (2006) Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 17: 2034-2047.
9. Henry RMA, Kostense PJ, Bos G, Dekker JM, Nijpels G, et al. (2002) Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int 62: 1402-1407.
10. Garg AX, Clark WF, Haynes RB, House AA. (2002) Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I. Kidney Int 61: 1486-1494.
11. Muntner P, He J, Hamm L, Loria C, Whelton PK (2002) Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13: 745-753.
12. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305.
13. Leeder SR, Mitchell P, Liew G, Rochtchina E, Smith W, et al. (2006) Low hemoglobin, chronic kidney disease, and risk for coronary heart disease-related death: The Blue Mountains Eye Study. J Am Soc Nephrol 17: 279-284.
14. Brugts JJ, Knetsch AM, Mattace-Raso FUS, Hofman A, Witteman JCM (2005) Renal function and risk of myocardial infarction in an elderly population: The Rotterdam Study. Arch Intern Med 165: 2659-2665.
15. Meisinger C, Doring A, Lowel Hfor the KORA Study Group (2006) Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J 27: 1245-1250.
16. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, et al. (2004) Chronic kidney disease as a risk factor for cardiovascular disease and allcause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 15: 1307-1315.
17. Knight EL, Rimm EB, Pai JK, Rexrode KM, Cannuscio CC, et al. (2004) Kidney dysfunction, inflammation, and coronary events: A prospective study. J Am Soc Nephrol 15: 1897-1903.
18. Van Biesen W, De Bacquer D, Verbeke F, Delanghe J, Lameire N, et al. (2007) The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur Heart J 28: 478-483.
19. Jonsdottir LS, Sigfusson N, Gunason V, Sigvaldason H, Thorgeirsson G (2002) Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. J Cardiovas Risk 9: 67-76.
20. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, et al. (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90: 583-612.
21. Viktorsdottir O, Palsson R, Andresdottir MB, Aspelund T, Gudnason V, et al. (2005) Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults. Nephrol Dial Transplant 20: 1799-1807.
22. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41.
23. Levey A, Greene T, Kusek J, Beck G (2000) A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 11: 155A.
24. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350: 1387-1397.
25. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, et al. (2003) National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139: 137-147.
26. Easton D, Peto J, Babiker A (1991) Floating absolute risk: An alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 10: 1025-1035.
27. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, et al. (1999) Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 150: 341-353.
28. Rosner B, Willett WC, Spiegelman D (1989) Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. Stat Med 8: 1051-1069.
29. Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
30. Rose G. (1981) Strategy of prevention: Lessons from cardiovascular disease. Br Med J (Clin Res Ed) 282: 1847-1851.
31. Baigent C, Landray M, Warren M (2004) Statin therapy in kidney disease populations: Potential benefits beyond lipid lowering and the need for clinical trials. Curr Opin Nephrol Hypertens 13: 601-605.
32. Remuzzi G, Perico N, Macia M, Ruggenenti P (2005) The role of reninangiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int (Suppl): S57-S65.
33. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, et al. for the European Uremic Toxin Work Group (EUTox) (2005) Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20: 1048-1056.
34. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12.
35. Wannamethee SG, Shaper AG, Lowe GD, Lennon L, Rumley A, et al. (2006) Renal function and cardiovascular mortality in elderly men: The role of inflammatory, procoagulant, and endothelial biomarkers. Eur Heart J 27: 2975-2981.
36. Kronenberg F, Kuen E, Ritz E, Junker R, Konig P, et al. (2000) Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 11: 105-115.
37. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, et al. (2003) Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107: 87-92.
38. Culleton BF, Larson MG, Wilson PWF, Evans JC, Parfrey PS, et al. (1999) Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney International 56: 2214-2219.
39. Tracy RE, Bhandaru SY, Oalmann MC, Guzman MA, Newmann WP III (1991) Blood pressure and nephrosclerosis in black and white men and women aged 25 to 54. Mod Pathol 4: 602-609.
40. Tracy RE, Strong JP, Newman WP III, Malcom GT, Oalmann MC, et al. (1996) Renovasculopathies of nephrosclerosis in relation to atherosclerosis at ages 25 to 54 years. Kidney Int 49: 564-570.
41. Verhave JC, Gansevoort RT, Hillege HL, de Zeeuw D, Curhan GC, et al. (2004) Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function. J Am Soc Nephrol 15: 1316-1322.
42. Bostom AG, Kronenberg F, Ritz E (2002) Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 13: 2140-2144.
43. Levey AS, Coresh J, Greene T, Stevens LA, Zhang Y, et al. for the Chronic Kidney Disease Epidemiology Collaboration (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254.
44. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, et al. for the National Kidney Disease Education Program Laboratory Working Group (2006) Recommendations for improving serum creatinine measurement: A report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 52: 5-18.
45. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, et al. (2006) Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145: 237-246.
46. Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, Fliser D (2006) Symmetric dimethylarginine (SDMA) as endogenous marker of renal function - A meta-analysis. Nephrol Dial Transplant 21: 2446-2451.
47. Wang J, Sim AS, Wang XL, Salonikas C, Naidoo D, et al. (2006) Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease. Atherosclerosis 184: 383-388.
48. Volkova N, McClellan W, Soucie JM, Schoolwerth A (2006) Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients. Nephrol Dial Transplant 21: 2202-2209.